Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Exonuclease Removal of Dideoxycytidine (Zalcitabine) by the Human Mitochondrial DNA Polymerase
Antimicrobial Agents and Chemotherapy, 01/17/08
Hanes JW et al. - In addition, we provide a more accurate measurement of the rate of excision and show that the low rate of removal of ddCMP results from both the unfavorable transfer of the primer strand from the polymerase to the exonuclease site and the inefficient binding and/or hydrolysis at the exonuclease site. The analogs ddC, stavudine, and ddATP (a metabolite of didanosine) each bind more tightly at the polymerase site during incorporation than normal nucleotides, and this tight binding contributes to slower excision by the proofreading exonuclease, leading to increased toxicity toward mitochondrial DNA
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infection: a meta-analysis
Current Medical Research and Opinion, 12/17/09
Artesunate plus amodiaquine combination therapy: reviewing the evidence
Drug Development Research, 12/17/09
Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux
Expert Review of Anti-infective Therapy, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


